Patients' Perspectives, Experiences, and Concerns With Perianal Fistulae: Insights From Online Targeted-Disease Forums.

Crohn’s disease netnography patient perspectives perianal fistula social media

Journal

Crohn's & colitis 360
ISSN: 2631-827X
Titre abrégé: Crohns Colitis 360
Pays: England
ID NLM: 101752188

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 01 08 2023
medline: 4 12 2023
pubmed: 4 12 2023
entrez: 4 12 2023
Statut: epublish

Résumé

Perianal fistulae can undermine physical, emotional, and social well-being in patients with Crohn's disease and are challenging to manage. Social media offers a rich opportunity to gain an in-depth understanding of the impact of perianal fistulae on patients' daily lives outside of controlled environments. In this study, we conducted social media analytics to examine patients' experiences with perianal fistulae and assessed the impact of perianal fistulae on patients' behavior and overall well-being. We used a mixed-method approach to examine 119 986 publicly available posts collected from 10 Crohn's disease forums in the United States between January 01, 2010 and January 01, 2020. Discussions related to Crohn's perianal fistulae were retrieved. We randomly selected 700 posts and qualitatively analyzed them using an inductive thematic approach. We then applied a latent Dirichlet allocation probabilistic topic model to explore themes in an unsupervised manner on the collection of 119 986 posts. In the qualitative analysis, 5 major themes were identified: (1) burden of perianal fistula; (2) challenges associated with treatment; (3) online information seeking and sharing; (4) patient experiences with treatments; and (5) patients' apprehension about treatments. In the quantitative analysis, the percentages of posts related to the major themes were (1) 20%, (2) 29%, (3) 66%, and (4) 28%, while the topic model did not identify theme 5. Social media reveals a dynamic range of themes governing patients' perspectives and experiences with Crohn's perianal fistulae. In addition to the biopsychosocial burden, patients frequently express dissatisfaction with current treatments and often struggle to navigate among available management options.

Sections du résumé

Background UNASSIGNED
Perianal fistulae can undermine physical, emotional, and social well-being in patients with Crohn's disease and are challenging to manage. Social media offers a rich opportunity to gain an in-depth understanding of the impact of perianal fistulae on patients' daily lives outside of controlled environments. In this study, we conducted social media analytics to examine patients' experiences with perianal fistulae and assessed the impact of perianal fistulae on patients' behavior and overall well-being.
Methods UNASSIGNED
We used a mixed-method approach to examine 119 986 publicly available posts collected from 10 Crohn's disease forums in the United States between January 01, 2010 and January 01, 2020. Discussions related to Crohn's perianal fistulae were retrieved. We randomly selected 700 posts and qualitatively analyzed them using an inductive thematic approach. We then applied a latent Dirichlet allocation probabilistic topic model to explore themes in an unsupervised manner on the collection of 119 986 posts.
Results UNASSIGNED
In the qualitative analysis, 5 major themes were identified: (1) burden of perianal fistula; (2) challenges associated with treatment; (3) online information seeking and sharing; (4) patient experiences with treatments; and (5) patients' apprehension about treatments. In the quantitative analysis, the percentages of posts related to the major themes were (1) 20%, (2) 29%, (3) 66%, and (4) 28%, while the topic model did not identify theme 5.
Conclusions UNASSIGNED
Social media reveals a dynamic range of themes governing patients' perspectives and experiences with Crohn's perianal fistulae. In addition to the biopsychosocial burden, patients frequently express dissatisfaction with current treatments and often struggle to navigate among available management options.

Identifiants

pubmed: 38046445
doi: 10.1093/crocol/otad073
pii: otad073
pmc: PMC10693318
doi:

Types de publication

Journal Article

Langues

eng

Pagination

otad073

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.

Références

Inflamm Bowel Dis. 2020 Jan 1;26(1):1-10
pubmed: 31112238
Eur J Health Econ. 2019 Jun;20(Suppl 1):91-100
pubmed: 31102158
Front Surg. 2022 Jan 24;8:806497
pubmed: 35141271
PLoS One. 2011 Apr 27;6(4):e19256
pubmed: 21556358
Gut. 2021 Sep;70(9):1649-1656
pubmed: 33272978
Int J Colorectal Dis. 2014 Oct;29(10):1285-90
pubmed: 24986138
Curr Opin Gastroenterol. 2021 Jul 1;37(4):328-335
pubmed: 33859103
J Mark Access Health Policy. 2023 Jan 15;11(1):2166374
pubmed: 36684854
Clin Gastroenterol Hepatol. 2018 Dec;16(12):1879-1892
pubmed: 29374617
United European Gastroenterol J. 2018 Mar;6(2):310-321
pubmed: 29511561
Arthritis Care Res (Hoboken). 2019 Feb;71(2):323-330
pubmed: 29781587
Crohns Colitis 360. 2021 Jul 07;3(3):otab044
pubmed: 36776642
Inflamm Bowel Dis. 2019 Feb 21;25(3):587-591
pubmed: 30203036
Gastroenterology. 2002 Apr;122(4):875-80
pubmed: 11910338
Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):563-577
pubmed: 31023087
J Urol. 2020 May;203(5):962-968
pubmed: 31855097
World J Gastroenterol. 2009 Sep 14;15(34):4263-72
pubmed: 19750568
Int J Colorectal Dis. 2015 Sep;30(9):1275-9
pubmed: 25994782
Inflamm Bowel Dis. 2008 Dec;14(12):1707-14
pubmed: 18618630
Vaccine. 2009 Nov 5;27(47):6546-9
pubmed: 19729083
Mayo Clin Proc. 2011 Sep;86(9):845-50
pubmed: 21878595
Health Qual Life Outcomes. 2020 Nov 20;18(1):370
pubmed: 33218361
Dig Dis Sci. 2013 Dec;58(12):3400-6
pubmed: 24026400
Ann Intern Med. 2011 May 17;154(10):707-8
pubmed: 21576547
BMC Med Res Methodol. 2011 May 18;11:72
pubmed: 21592352
WMJ. 2010 Oct;109(5):261-6
pubmed: 21066931

Auteurs

Carine Khalil (C)

Division of Health Services Research, Cedars-Sinai Medical Center, Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA.

Welmoed K van Deen (WK)

Division of Health Services Research, Cedars-Sinai Medical Center, Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA.
Erasmus School of Health Policy & Management, Rotterdam, The Netherlands.

Taylor Dupuy (T)

Division of Health Services Research, Cedars-Sinai Medical Center, Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA.

Gaurav Syal (G)

Cedars-Sinai Medical Center, Department of Medicine, Los Angeles, CA, USA.

Corey Arnold (C)

Medical Imaging Informatics, Department of Radiology, UCLA, Los Angeles, CA, USA.

Susan E Cazzetta (SE)

Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.

Pradeep P Nazarey (PP)

Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.

Christopher V Almario (CV)

Division of Health Services Research, Cedars-Sinai Medical Center, Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA.

Brennan M R Spiegel (BMR)

Division of Health Services Research, Cedars-Sinai Medical Center, Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA.

Classifications MeSH